Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001564590-19-046005
Filing Date
2019-12-16
Accepted
2019-12-16 07:02:12
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A achv-s1a.htm S-1/A 1257014
2 EX-1.1 achv-ex11_117.htm EX-1.1 593432
3 EX-3.12 achv-ex312_142.htm EX-3.12 143490
4 EX-4.9 achv-ex49_118.htm EX-4.9 152941
5 EX-5.1 achv-ex51_97.htm EX-5.1 22197
6 EX-10.29 achv-ex1029_96.htm EX-10.29 25087
7 EX-23.1 achv-ex231_7.htm EX-23.1 2723
8 GRAPHIC gq0oycdzpjr1000003.jpg GRAPHIC 4182
9 GRAPHIC gq0oycdzpjr1000002.jpg GRAPHIC 30837
10 GRAPHIC gq0oycdzpjr1000001.jpg GRAPHIC 4182
11 GRAPHIC gnuejcr4u0iv000001.jpg GRAPHIC 7143
  Complete submission text file 0001564590-19-046005.txt   2262541
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-234530 | Film No.: 191285846
SIC: 2835 In Vitro & In Vivo Diagnostic Substances